Richard Scheller News Today

Ipo, and another merger might be in the works. More sales are said to be in talks. First, to our lead, the square ipo. The Payments Company filing for an initial public offering, looking to raise 275 million. That number is a placeholder and will probably change. Jack dorsey is pulling double duty as ceo of square and twitter will have to juggle for square as he tries to restructure the company. Joining me now is alex barinka, who covers ipos, and the bloomberg head of global technology, brad st...

Investigation for processing transactions for iranians and sunnis, violating sanctions. The police are using showcasing stew find a person who opened fire on two officers in ferguson, missouri, last night. One of them was shot in the face. They were shot outside the police station. Both have been released from the hospital. We know those two officers took a very hard hit. Any time you take a bullet to the face and have a bullet lodged in your head one going through the middle of your right back ...

Very hard hit. Any time youre shot in the face and have a bullet lodged in your head, any time you have a throughandthrough wound where the bullet enters your shoulder and comes out the middle of your right back those are hard hit. Were lucky, by gods grace, we didnt lose two officers last night. Cory the officers have been released state police are assuming control of ferguson. Protests rose again after the police chief arrived fol resigned following a report that showed extreme bias. Disney an...

Head, any time you have a throughandthrough wound where the bullet enters your shoulder and comes out the middle of your right back, those are hard hit. Were lucky, by gods grace, we didnt lose two officers last night. Cory the officers have been released. State police are assuming control of ferguson tonight. Protests rose again after the police chief resigned following a scathing Justice Department report that showed extreme bias. Accused the department of extreme bias. Disney shares took off ...

/PRNewswire/ -- Velia Therapeutics, a biotechnology company focused on the discovery and development of a new generation of protein-based therapeutics that...

BioPharma

Dr. McHutchison is a world-renowned physician, scientist, and drug developer who has led the research and development of numerous marketed therapies for...

Stanford President Marc Tessier-Lavigne has declined to answer dozens of questions and made statements about his research that contradict accounts of fellow researchers, Genentech and the scientific record. Meanwhile, professors have publicly questioned his ability to lead as he grapples with mounting allegations.

An email contained additional allegations about Marc Tessier-Lavigne’s Alzheimer’s research and the 2011 internal review that former colleagues allege uncovered falsification.

23.02.2023 - –Phase 3 ATTRibute-CM registrational trial of acoramidis for transthyretin amyloid cardiomyopathy (ATTR-CM) continues to have high operating fidelity; month 30 topline registrational data are expected to be announced in mid-2023 –Phase 2 PROPEL 2 ...